Search research articles
Contact Us
Filters
Showing results (351-360 of 497) with videos related to
Page
of 50
Sort By:
Journal of Virology
|
August 10, 1999
R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus
R D Berkowitz, A B van't Wout, N A Kootstra, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 10, 2014
Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers
M Levi, K T Moore, C F Castillejos, et al.
Clinical Cardiology
|
October 17, 2022
Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD
Marc P Bonaca, Michael Szarek, E Sebastian Debus, et al.
JACC. Cardiovascular Interventions
|
March 21, 2025
Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial
R Kevin Rogers, Eike Sebastian Debus, Manesh R Patel, et al.
JAMA
|
February 11, 2005
Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial
Jean-Noel Fiessinger, Menno V Huisman, Bruce L Davidson, et al.
Journal of Virology
|
November 13, 1998
CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo
R D Berkowitz, S Alexander, C Bare, et al.
The New England Journal of Medicine
|
October 31, 2003
Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement
Charles W Francis, Scott D Berkowitz, Philip C Comp, et al.
Ultrasound in Medicine & Biology
|
July 1, 1999
Determination of carotid plaque risk by ultrasonic tissue characterization
D J Lee, B Sigel, V K Swami, et al.
Journal of the American College of Cardiology
|
February 4, 2021
Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial
Tomasz J Guzik, Chinthanie Ramasundarahettige, Nana Pogosova, et al.
Journal of Vascular Surgery
|
July 1, 1993
Infrageniculate bypass graft entrapment
J P Carpenter, M D Lieberman, R Shlansky-Goldberg, et al.
Page
of 50
Search research articles
Search
Showing results (351-360 of 497) with videos related to
Sort By:
Page
of 50
Journal of Virology
|
August 10, 1999
R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus
R D Berkowitz, A B van't Wout, N A Kootstra, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 10, 2014
Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers
M Levi, K T Moore, C F Castillejos, et al.
Clinical Cardiology
|
October 17, 2022
Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD
Marc P Bonaca, Michael Szarek, E Sebastian Debus, et al.
JACC. Cardiovascular Interventions
|
March 21, 2025
Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial
R Kevin Rogers, Eike Sebastian Debus, Manesh R Patel, et al.
JAMA
|
February 11, 2005
Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial
Jean-Noel Fiessinger, Menno V Huisman, Bruce L Davidson, et al.
Journal of Virology
|
November 13, 1998
CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo
R D Berkowitz, S Alexander, C Bare, et al.
The New England Journal of Medicine
|
October 31, 2003
Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement
Charles W Francis, Scott D Berkowitz, Philip C Comp, et al.
Ultrasound in Medicine & Biology
|
July 1, 1999
Determination of carotid plaque risk by ultrasonic tissue characterization
D J Lee, B Sigel, V K Swami, et al.
Journal of the American College of Cardiology
|
February 4, 2021
Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial
Tomasz J Guzik, Chinthanie Ramasundarahettige, Nana Pogosova, et al.
Journal of Vascular Surgery
|
July 1, 1993
Infrageniculate bypass graft entrapment
J P Carpenter, M D Lieberman, R Shlansky-Goldberg, et al.
Page
of 50